SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wang AY, Wang M, Woo J et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J. Am. Soc. Nephrol. 2004; 15: 218694.
  • 2
    Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am. J. Kidney Dis. 2001; 38: 8590.
  • 3
    Chandna SM, Farrington K. Residual renal function: Considerations on its importance and preservation in dialysis patients. Semin. Dial. 2004; 17: 196201.
  • 4
    Caramelo C, Alcazar R, Gallar P et al. Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients. Nephrol. Dial. Transplant. 1994; 9: 6757.
  • 5
    Davies S. Are PD patients with or without residual renal function qualitatively different, or are they simply at different stages of the continuum of progressive uraemia? Nephrol. Dial. Transplant. 2005; 20: 27072.
  • 6
    Lameire NH. The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron 1997; 77: 1328.
  • 7
    Keshaviah P, Collins AJ, Ma JZ, Churchill DN, Thorpe KE. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy. J. Am. Soc. Nephrol. 2002; 13 (Suppl. 1): S4852.
  • 8
    Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J. Am. Soc. Nephrol. 2001; 12: 215862.
  • 9
    Termorshuizen F, Dekker FW, Van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of the Netherlands cooperative study on the adequacy of dialysis (NECOSAD)-2. J. Am. Soc. Nephrol. 2004; 15: 106170.
  • 10
    Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Are peritoneal dialysis patients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death. Nephrol. Dial. Transplant. 2003; 18: 97782.
  • 11
    Johnson DW, Mudge DW, Sturtevant JM et al. Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit. Dial. Int. 2003; 23: 27683.
  • 12
    Wang T, Ye RG, Zhen ZH, Li HQ, Mai WY. Influence of peritoneal dialysis on the progression of chronic renal failure. Adv. Perit. Dial. 1995; 11: 13941.
  • 13
    Korevaar JC, Jansen MA, Dekker FW et al.; Netherlands Cooperative Study on the Adequacy of Dialysis Study Group. When to initiate dialysis: Effect of proposed US guidelines on survival. Lancet 2001; 358: 104650.
  • 14
    Schiffl H. Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients. Nephrol. Dial. Transplant. 1995; 10: 91112.
  • 15
    Tattersall J, Greenwood R, Farrington K. Urea kinetics and when to commence dialysis. Am. J. Nephrol. 1995; 15: 2839.
  • 16
    Piccoli GB, Burdese M, Mezza E et al. Maintenance of residual renal function 10 years after the start of hemodialysis: The advantage of tailored schedules? Int. J. Artif. Organs 2004; 27: 2514.
  • 17
    Assounga A, Canaud B, Flavier JL et al. What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis? Nephrologie 1987; 8: 3016.
  • 18
    Amici G, Virga G, Da Rin G et al. Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis. Nephron 1993; 65: 46971.
  • 19
    Hakim RM, Wingard RL, Husni L, Parker RA, Parker TF 3rd. The effect of membrane biocompatibility on plasma beta 2-microglobulin levels in chronic hemodialysis patients. J. Am. Soc. Nephrol. 1996; 7: 4728.
  • 20
    Szeto CC, Lai KN, Wong TY et al. Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis. 1999; 34: 105664.
  • 21
    Suda T, Hiroshige K, Ohta T et al. The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol. Dial. Transplant. 2000; 15: 396401.
  • 22
    Wang AY, Sea MM, Ip R et al. Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis. Am. J. Clin. Nutr. 2002; 76: 56976.
  • 23
    Suliman ME, Heimburger O, Barany P et al. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J. Am. Soc. Nephrol. 2003; 14: 161422.
  • 24
    Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT; NECOSAD Study Group. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am. J. Kidney Dis. 2003; 41: 1293302.
  • 25
    Gunal AI, Kirciman E, Guler M, Yavuzkir M, Celiker H. Should the preservation of residual renal function cost Volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients? Ren. Fail. 2004; 26: 4059.
  • 26
    Hidaka H, Nakao T. Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis. Nephrology. 2003; 8: 18491.
  • 27
    Lutes R, Perlmutter J, Holley JL, Bernardini J, Piraino B. Loss of residual renal function in patients on peritoneal dialysis. Adv. Perit. Dial. 1993; 9: 1658.
  • 28
    Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit. Dial. Int. 2000; 20: 42938.
  • 29
    Shemin D, Bostom AG, Lambert C, Hill C, Kitsen J, Kliger AS. Residual renal function in a large cohort of peritoneal dialysis patients: Change over time, impact on mortality and nutrition. Perit. Dial. Int. 2000; 20: 43944.
  • 30
    Horinek A, Misra M. Does residual renal function decline more rapidly in hemodialysis than in peritoneal dialysis? How good is the evidence? Adv. Perit. Dial. 2004; 20: 13740.
  • 31
    Misra M, Vonesh E, Churchill DN, Moore HL, Van Stone JC, Nolph KD. Preservation of glomerular filtration rate on dialysis when adjusted for patient dropout. Kidney Int. 2000; 57: 6916.
  • 32
    Jansen MA, Hart AA, Korevaar JC et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002; 62: 104653.
  • 33
    Moist LM, Port FK, Orzol SM et al. Predictors of loss of residual renal function among new dialysis patients. J. Am. Soc. Nephrol. 2000; 11: 55664.
  • 34
    Hung AM, Young BS, Chertow GM. The decline in residual renal function in hemodialysis is slow and age dependent. Hemodialysis Intern. 2003; 7: 17.
  • 35
    Schiffl H, Mucke C, Lang SM. Rapid decline of residual renal function in patients with late renal transplant failure who are re-treated with CAPD. Perit. Dial. Int. 2003; 23: 398400.
  • 36
    Chung SH, Heimburger O, Stenvinkel P, Bergstrom J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol. Dial. Transplant. 2001; 16: 224045.
  • 37
    Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA. Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am. J. Kidney Dis. 1999; 34: 1420.
  • 38
    Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int. 2001; 59: 112833.
  • 39
    Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann. Intern. Med. 2003; 139: 10512.
  • 40
    Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am. J. Kidney Dis. 2004; 43: 105664.
  • 41
    Lang SM, Bergner A, Topfer M, Schiffl H. Preservation of residual renal function in dialysis patients: Effects of dialysis-technique-related factors. Perit. Dial. Int. 2001; 21: 52.
  • 42
    Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int. Suppl. 1993; 40: S10610.
  • 43
    McCarthy JT, Jenson BM, Squillace DP, Williams AW. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers. Am. J. Kidney Dis. 1997; 29: 57683.
  • 44
    Hartmann J, Fricke H, Schiffl H. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis. Am. J. Kidney Dis. 1997; 30: 36673.
  • 45
    McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int. 2002; 61: 25665.
  • 46
    Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A. Rapid decline of residual renal function in patients on automated peritoneal dialysis. Perit. Dial. Int. 1996; 16: 30715.
  • 47
    Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, Mignon F. The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol. Dial. Transplant. 1999; 14: 12248.
  • 48
    Van Biesen W, Lameire NH. Residual renal function in automated peritoneal dialysis. Contrib. Nephrol. 1999; 129: 22946.
  • 49
    Ward RA. Ultrapure dialysate. Semin. Dial. 2004; 17: 48997.
  • 50
    Chung SH, Heimburger O, Stenvinkel P, Qureshi AR, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol. Dial. Transplant. 2003; 18: 59097.
  • 51
    Heimburger O. Residual renal function, peritoneal transport characteristics and dialysis adequacy in peritoneal dialysis. Kidney Int. Suppl. 1996; 56: S4755.
  • 52
    Schiffl H, Lang SM, Fischer R. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol. Dial. Transplant. 2002; 17: 181418.
  • 53
    Katzarski KS, Charra B, Luik AJ et al. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol. Dial. Transplant. 1999; 14: 36975.
  • 54
    Stegmayr BG. Ultrafiltration and dry weight-what are the cardiovascular effects? Artif. Organs 2003; 27: 2279.
  • 55
    Ozkahya M, Ok E, Cirit M et al. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol. Dial. Transplant. 1998; 13: 148993.
  • 56
    Özkahya M, Toz H, Özerkan F et al. Impact of Volume control on left ventricular hypertrophy in dialysis patients. J. Nephrol. 2002; 15: 65560.
  • 57
    Konings CJAM, Kooman JP, Schonck M et al. Fluid status in CAPD patients is related to peritoneal transport residual renal function: Evidence from a longitudinal study. Nephrol. Dial. Transplant. 2003; 18: 797803.
  • 58
    Wang AY, Wang M, Woo J et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int. 2002; 62: 63947.
  • 59
    Panagoutsos S, Kantartzi K, Passadakis P et al. Timely transfer of peritoneal dialysis patients to hemodialysis improves survival rates. Clin. Nephrol. 2006; 65: 437.
  • 60
    Shahid M. Chandna and Ken Farrington. Residual renal function: Considerations on its importance and preservation in dialysis patients. Semin. Dial. 2004; 17: 196.
  • 61
    Cheng LT, Tang W, Wang T. Strong association between Volume status and nutritional status in peritoneal dialysis patients. Am. J. Kidney Dis. 2005; 45: 891902.
  • 62
    London GM, Pannier B, Guerin AP et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J. Am. Soc. Nephrol. 2001; 12: 275967.
  • 63
    Charra B. Dry weight’ in dialysis: The history of a concept. Nephrol. Dial. Transplant. 1998; 13: 18825.
  • 64
    Chazot C, Charra B, Vo Van C et al. The Janus-faced aspect of ‘’dry weight. Nephrol. Dial. Transplant. 1999; 14: 1214.
  • 65
    Venkataraman V, Nolph KD. Preservation of residual renal function: An important goal. Perit. Dial. Int. 2000; 20: 3925.